c6 peptide b burgdorferi is significantly more specific for detection of B. burgdorferi infection - LymeC6 peptidetest possesses high immunogenicity Understanding the C6 Peptide in Borrelia burgdorferi Detection

Lyme QuantC6test cost The C6 peptide has emerged as a crucial tool in the serological diagnosis of Lyme disease, primarily due to its high specificity and sensitivity in detecting antibodies against _Borrelia burgdorferi_, the bacterium responsible for the illness. This synthetic peptide, derived from the VlsE protein of _Borrelia burgdorferi_, represents an invariant region (IR6) that is highly conserved across different strains of the bacteria.C6 Peptide-Based Multiplex Phosphorescence Analysis ... This conservation makes the C6 peptide a reliable target for antibody detection, offering a significant advantage over other diagnostic markers.

Expertise and Experience in Lyme Disease Diagnostics:

Research and clinical applications have consistently demonstrated the efficacy of C6 peptide-based assays. Multiple studies, including those by Marques et al. (2002) and Jansson et al. (2005), have confirmed that the C6 peptide enzyme-linked immunosorbent assay (ELISA) is highly specific for _B作者：ES Theel·2016·被引用次数：86—Among the different VlsE IRs,IR6 was identified as an immunodominant epitope for B. burgdorferi sl, and an ELISA using a recombinant 26-amino .... burgdorferi_ and does not cross-react with antibodies to other pathogens, such as anti-OspA antibodies. This specificity is critical for accurate diagnosis, minimizing the risk of false positivesC6 Titers In Treated and Untreated, Symptomatic Lyme .... Furthermore, Levy et al. (2008) have shown that antibodies to the C6 peptide are a strong indicator of natural infection with _Borrelia burgdorferi_ and that these antibody levels tend to decline following successful treatment in both dogs and humans. This characteristic makes the C6 peptide useful not only for initial diagnosis but also for monitoring treatment response. The development of the Borrelia burgdorferi C6 Peptide Antibody assay in 2014 was a significant advancement, offering improved specificity for detecting _B. burgdorferi_ infectionRecent studies have shown that theC6 peptide is a sensitive and specific marker for antibody to B. burgdorferisensu lato and for the serodiagnosis of Lyme ....

The Science Behind the C6 Peptide Assay:

The C6 peptide is a 25-amino acid sequence derived from the IR6 region of the VlsE protein of _Borrelia burgdorferi_. The VlsE protein itself is known for its ability to undergo antigenic variation, allowing the spirochete to evade the host's immune system. However, the IR6 region remains relatively constant. When an individual is infected with _B. burgdorferi_, their immune system produces antibodies against various components of the bacterium, including the VlsE protein. The C6 peptide acts as a surrogate marker for these antibodies.作者：GP Wormser·2018·被引用次数：11—WCS EIA and theC6 peptideEIA for antibody toB.burgdorferiare not independent tests. Independence between tests is usually attributable ...

The most common diagnostic method utilizing the C6 peptide is the C6 peptide ELISA (Enzyme-Linked Immunosorbent Assay). This test detects both IgG and IgM antibodies that are specific to the C6 peptide. The presence of these antibodies, particularly in conjunction with clinical symptoms, is highly suggestive of Lyme disease. Several laboratories offer this test, often referred to as the Lyme C6 Ab, Total or Lyme Disease C6 Ab, Total. The Immunetics C6 B. burgdorferi (Lyme) ELISA Kit is an example of a commercial assay designed for the presumptive detection of these antibodies.Two-Tiered Antibody Testing for Lyme Disease With Use of 2 ...

Advantages and Applications of the C6 Peptide Test:

The C6 peptide assay offers several advantages:

* High Specificity: As highlighted by Marques et alTest ID: FBBC6 Secondary ID: 91899. (2002), the C6 peptide ELISA exhibits very high specificity for _B.Quantitative measurement of C6 antibody following ... burgdorferi_, reducing the likelihood of false positive results. This means the test is less likely to indicate an infection when one is not present.

* Improved Sensitivity: Compared to earlier diagnostic methods, the C6 Peptide ELISA demonstrates enhanced sensitivity, meaning it is better at detecting infections when they are present. This is crucial for early diagnosis and timely treatment.Lyme Disease C6 Ab, Total

* Detection of Both IgG and IgM: The assay can detect both IgG and IgM antibodies. IgM antibodies are typically the first to appear after infection, while IgG antibodies persist longer and can indicate a past or chronic infection. Detecting both provides a more comprehensive picture of the infection status.The Immunetics C6 B. burgdorferi (Lyme) ELISA Kit is intended for use in thepresumptive detection of IgG and IgM antibodies to B. burgdorferi in human ...

* Monitoring Treatment: The ability of the C6 peptide antibody levels to decline after treatment, as observed by Levy et al. (2008), makes it a valuable tool for assessing the effectiveness of Lyme disease therapy.

* Potential for Detecting Other Borrelia Species: Emerging research suggests that the C6 peptide test might also be useful in identifying infections caused by other Borrelia species, such as _Borrelia miyamotoi_. Studies by Molloy et al. (2018) and van Burgel et alThis ELISA detects both IgG and IgM antibodies against theC6 peptide derived from the V1sE protein of Borrelia burgdorferi, the causative agent of Lyme disease .... (2011) have explored this possibility, indicating the broader utility of this diagnostic marker. For instance, a study by Christova et al. (2013) showed that C6 peptides could be successfully used for diagnosis in up to 80% of patients with early Lyme borreliosis作者：C Jansson·2005·被引用次数：32—Overall, it was concluded that theC6 peptideand IgG ELISAs can be used as a first step for detecting B. burgdorferi. If the results concur, the confirmatory ....

While the C6 peptide is a highly effective diagnostic tool, it is often used as part of a two-tiered testing strategy for Lyme diseaseLyme Disease C6 Ab, Total - Test Definition. This approach typically involves an initial screening test, such as an EIA using the C6 peptide, followed by a confirmatory test, like a Western blot, if the initial results are positive or equivocal. However, some studies, like the one by Branda et al. (2011), suggest that a single EIA using the C6 peptide can provide similar or even better results than traditional multi-test approaches.Evaluation of a sequential enzyme immunoassay testing ...

It is important to note that while the C6 peptide is a powerful diagnostic marker for _Borrelia burgdorferi_ infection, it is essential to interpret test results in the context of a patient's clinical presentation and exposure historyRecent studies have shown that theC6 peptide is a sensitive and specific marker for antibody to B. burgdorferisensu lato and for the serodiagnosis of Lyme .... The C6 peptide itself, as identified by Theel et al.[Heterogeneity of canine immune responses to Borrelia ... (2016), is an immunodominant epitope within the VlsE protein, contributing to its effectiveness as a diagnostic targetC6 PePtIdes froM BORRELIA BuRgdORfERI seNsU strICto .... The C6 peptide is considered a sensitive and specific marker for antibodies to _B. burgdorferi_.2Antibodies to the C6 peptide are an indication of natural infection with B. burgdorferi. Surface proteins change with different stages of infection. Osp ... The fact that both antigens have been considered specific for a Borrelia infection underscores the significance of the C6 peptide in this regard. The high immunogenicity of the C6 peptide is a key factor in its diagnostic utility作者：V Pomelova·2018—We evaluated the utility ofBorrelia burgdorferi sensu stricto (Bb) peptide C6for serologic confirmation of Ixodid Tick-Borne Borrelioses (ITBB) in Russia..